Kala Pharmaceuticals, Inc. (KALA) has 31 open-market insider trades by 16 insiders since 2017. The most active filer is Rajeev M. Shah, 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rajeev M. Shah | 10% Owner | — | 4 | $150.2M | 2022-05-25 |
| Peter Kolchinsky | 10% Owner | — | 3 | $108.7M | 2022-05-26 |
| Gregory Grunberg | Dir | — | 3 | $48.2M | 2021-06-17 |
| RA Capital Management, LLC via Rajeev M. Shah | Dir10% Owner | — | 1 | $20.0M | 2018-10-03 |
| OrbiMed Capital GP VI LLC | 10% Owner | — | 2 | $11.8M | 2018-02-01 |
| Orbimed Advisors LLC | 10% Owner | — | 4 | $8.7M | 2018-02-08 |
| Samuel D. Isaly | 10% Owner | — | 1 | $4.8M | 2017-07-25 |
| Felix Baker | 10% Owner | — | 1 | $4.0M | 2024-12-30 |
| Bruce Kovner | 10% Owner | — | 1 | $3.2M | 2017-07-20 |
| Julian Baker | — | — | 1 | $1.8M | 2025-10-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Mark T. Iwicki | Director | Sell | $251K | 2025-10-23 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | $17K | 2025-10-22 |
| Todd Bazemore | Director | Sell | $40K | 2025-10-22 |
| Mary Reumuth | CFO | Sell | $28K | 2025-10-22 |
| Romulus K. Brazzell | SEE REMARKS | Sell | $39K | 2025-10-22 |
| Julian Baker | — | Sell | $1.8M | 2025-09-30 |
Companies that share insiders with KALA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mark T. Iwicki | Director | Sell | $106K | 2025-06-24 |
| Mary Reumuth | CFO | Sell | $15K | 2025-06-24 |
| Romulus K. Brazzell | SEE REMARKS | Sell | $21K | 2025-06-24 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | Sell | $18K | 2025-06-24 |
| Todd Bazemore | SEE REMARKS | Sell | $16K | 2025-06-24 |
| Todd Bazemore | SEE REMARKS | Sell | $13K | 2025-06-03 |
| Mark T. Iwicki | Director | Sell | $41K | 2025-06-03 |
| Romulus K. Brazzell | SEE REMARKS | Sell | $14K | 2025-06-03 |
| Mary Reumuth | CFO | Sell | $11K | 2025-06-03 |